Tamekia Wakefield, MD
Pediatric Otolaryngology · Flushing, NYNPI 1487656849
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 146 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations.
Across 146 payments — averaging $26.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$885
- Optinose US, Inc.$824
- Sanofi$792
- Neurent Medical Limited$227
- Stryker$183
- Hikma Pharmaceuticals USA$146
- plus $762 from 20 others
What the payments were for
- Food & beverage$3,76599%
- Education$531%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 30 | $885 |
| Optinose US, Inc. | 37 | $824 |
| Sanofi | 32 | $792 |
| Neurent Medical Limited | 4 | $227 |
| Stryker | 4 | $183 |
| Hikma Pharmaceuticals USA | 7 | $146 |
| Regeneron Healthcare Solutions, Inc. | 4 | $92 |
| Alk-abello, Inc | 5 | $85 |
| Lilly USA, LLC | 3 | $81 |
| Acclarent, Inc | 1 | $59 |
| Kaleo, Inc. | 3 | $59 |
| Amgen | 2 | $54 |
| Sanofi-aventis U.S. LLC | 1 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| Medtronic | 1 | $29 |
| Grifols USA, LLC | 1 | $29 |
| Integra Lifesciences Corporation | 1 | $28 |
| Merck | 1 | $24 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Boehringer Ingelheim | 1 | $18 |
| Shire North American Group Inc | 1 | $18 |
| Glenmark Therapeutics Inc. | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
| Smith+Nephew | 1 | $12 |
How this compares
$3,818 in reported general payments places this provider in the 85th percentile of 39 pediatric otolaryngology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 17 | $1,854 |
| Fluticasone Propionate | 146 | $1,485 |
| Ipratropium Bromide | 33 | $1,174 |
| Fluocinolone Acetonide Oil | 30 | $966 |
| Ofloxacin | 15 | $777 |
| Azelastine Hcl | 21 | $462 |
| Omeprazole | 45 | $269 |
| Mupirocin | 18 | $159 |
| Methylprednisolone | 20 | $112 |
| Famotidine | 14 | $72 |
Paid to pharmacies, not to this prescriber.
Other pediatric otolaryngology in Flushing
- Robert RubenBronx$20K
- Richard RosenfeldBrooklyn$12K
- Jennifer McLevy-BazzanellaValhalla$8K
- David MenerNew Rochelle$4K
- Jay DolitskyNew York$3K
- Stephanie WongRochester$1K
- Michael PizzutoBuffalo$1K
- Alyssa HackettBayside$1K
- Mark NagyBuffalo$1K
- Sanjay ParikhBronx$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.